Page 6 - Development Scientist News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Even if you have been hiding under a rock while social distancing, you’ve probably heard something about “CBD”, as the health craze for the product derived from the cannabis plant sweeps the globe. Chances are your mom, your greenie friend and your student nephew are probably already using cannabidiol (CBD) oil for various health reasons. CBD won’t get you high. Instead, quite the opposite as one of its possible health benefits includes naturally improving sleep, along with reducing inflammation, pain, and anxiety, without any of the potential side-effects of big pharma. Products cont...

COVID-19 and the Role of Neutralizing Antibodies (NAbs) Sponsored Content by ACROBiosystemsMar 2 2021 One of the big stories of the coronavirus pandemic has been COVID-19 neutralizing antibodies (NAbs). NAbs are produced by B cells within the immune system and are characterized by stopping infections through incapacitation of the invading pathogen. Coronavirus NAbs were heralded as a possible treatment and diagnostic target from the moment of the announcement of their discovery in May 2020. NAbs from SARS-CoV-2 usually form approximately 1-2 weeks following infection. Serologic tests cannot d...

Share this article Share this article VALDOSTA, Ga., Feb. 18, 2021 /PRNewswire/ -- CJB Applied Technologies, LLC, is pleased to announce Nigel Gilbert Chimbetete, Ph.D., has joined the company as a Bio-applications Scientist. In this new role, Dr. Chimbetete will oversee the new Bioconversions Lab at CJB and direct biological development projects for CJB's valued customers. Dr. Chimbetete joins CJB Applied Technologies, LLC, from Kraft-Heinz Company, where he worked as a Research and Development Scientist as part of the Technology Discovery and Development Team at Kraft's R&D Center in Waukeg...

Vancouver, Canada — Renaissance BioScience Corp., a leading global bioengineering company, is pleased to officially announce the publication of a landmark paper on lager yeast development in the February 2021 issue of Applied and Environmental Microbiology (Volume 87, Issue 3). “Industrially Applicable De Novo Lager Yeast Hybrids with a Unique Genome Architecture: Creation and Characterization,” by Turgeon et al, explains how the Renaissance research team developed an innovative approach in creating novel non-GMO lager yeast strains that are immediately suitable for lager beer productio...